NCT05493787 is a NA clinical trial of Reminder in Influenza, sponsored by Geisinger Clinic.

Who is sponsoring NCT05493787?

NCT05493787 is sponsored by Geisinger Clinic.

What drugs are being tested in NCT05493787?

Interventions in NCT05493787: Reminder.

Is NCT05493787 still recruiting?

NCT05493787 is currently completed. Last updated 30 December 2024.

Are results published for NCT05493787?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2024-12-30 · How we verify

NCT05493787

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Nudging Flu Vaccination by Making it Easy for Patients to Schedule a Flu Shot

Completed NA Results posted Last updated 30 December 2024

What this trial tests

NA trial testing Reminder in Influenza in 139,503 participants. Completed in 3 January 2023.

Timeline

8 November 2022

Primary endpoint
3 January 2023

3 January 2023

Quick facts

Lead sponsor	Geisinger Clinic
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	139,503
Start date	8 November 2022
Primary completion	3 January 2023
Estimated completion	3 January 2023
Sites	1 location across United States

Drugs / interventions tested

Reminder

Conditions studied

Influenza — all drugs for Influenza →

Sponsor

Geisinger Clinic

Who can join

18 and older, any sex, with Influenza. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Number of Patients Who Self-scheduled a Flu Shot Primary · Within 4 weeks of message send date

Patient self-schedules a flu vaccine appointment through the patient portal. This outcome measures whether the patient schedules an appointment within 4 weeks of the send date, but the appointment can occur more than 4 weeks past the send date.

Group	Value	95% CI
Passive Control - November	43
Active Control Message - November	63
Ease Message - November	62
Waiting for You Message - November	74
Protect Yourself - Rare Message	70
Protect Yourself - Frequent Message - November	53
Passive Control - December	8
Active Control Message - December	28
Ease Message - December	36
Waiting for You Message - December	44
Protect Yourself - Rare Message - December	20
Protect Yourself - Frequent Message - December	26

Flu Vaccination Secondary · Within 4 weeks of message send date

Number of patients who received a flu vaccine

Group	Value	95% CI
Passive Control - November	488
Active Control Message - November	450
Ease Message - November	468
Waiting for You Message - November	460
Protect Yourself - Rare Message - November	450
Protect Yourself - Frequent Message - November	478
Passive Control - December	146
Active Control Message - December	158
Ease Message - December	153
Waiting for You Message - December	177
Protect Yourself - Rare Message - December	142
Protect Yourself - Frequent Message - December	124

Number of Patients Who Self-Scheduled a Flu Shot by Sex Secondary · Within 4 weeks of the message send date

Patient self-schedules a flu vaccine through the patient portal This outcome measures whether the patient schedules an appointment within 4 weeks of the message send date, but the appointment can occur more than 4 weeks past the send date.

Female

Group	Value	95% CI
Passive Control - November	28
Active Control Message - November	38
Ease Message - November	46
Waiting for You Message - November	45
Protect Yourself - Rare Message - November	53
Protect Yourself - Frequent Message - November	31
Passive Control - December	6
Active Control Message - December	13
Ease Message - December	21
Waiting for You Message - December	25
Protect Yourself - Rare Message - December	11
Protect Yourself - Frequent Message - December	9

Male

Group	Value	95% CI
Passive Control - November	15
Active Control Message - November	25
Ease Message - November	16
Waiting for You Message - November	29
Protect Yourself - Rare Message - November	17
Protect Yourself - Frequent Message - November	22
Passive Control - December	2
Active Control Message - December	15
Ease Message - December	15
Waiting for You Message - December	19
Protect Yourself - Rare Message - December	9
Protect Yourself - Frequent Message - December	17

Number of Patients Who Self-Scheduled a Flu Shot by Race Secondary · Within 4 weeks of the message send date

American Indian or Alaska Native

Group	Value	95% CI
Passive Control - November	0
Active Control Message - November	0
Ease Message - November	0
Waiting for You Message - November	0
Protect Yourself - Rare Message - November	0
Protect Yourself - Frequent Message - November	0
Passive Control - December	0
Active Control Message - December	0
Ease Message - December	0
Waiting for You Message - December	0
Protect Yourself - Rare Message - December	0
Protect Yourself - Frequent Message - December	0

Asian

Group	Value	95% CI
Passive Control - November	2
Active Control Message - November	2
Ease Message - November	1
Waiting for You Message - November	1
Protect Yourself - Rare Message - November	0
Protect Yourself - Frequent Message - November	0
Passive Control - December	0
Active Control Message - December	0
Ease Message - December	0
Waiting for You Message - December	1
Protect Yourself - Rare Message - December	1
Protect Yourself - Frequent Message - December	0

Native Hawaiian or Other Pacific Islander

Group	Value	95% CI
Passive Control - November	0
Active Control Message - November	0
Ease Message - November	0
Waiting for You Message - November	1
Protect Yourself - Rare Message - November	1
Protect Yourself - Frequent Message - November	0
Passive Control - December	0
Active Control Message - December	0
Ease Message - December	0
Waiting for You Message - December	0
Protect Yourself - Rare Message - December	0
Protect Yourself - Frequent Message - December	0

Black or African American

Group	Value	95% CI
Passive Control - November	1
Active Control Message - November	4
Ease Message - November	4
Waiting for You Message - November	1
Protect Yourself - Rare Message - November	0
Protect Yourself - Frequent Message - November	1
Passive Control - December	0
Active Control Message - December	1
Ease Message - December	1
Waiting for You Message - December	3
Protect Yourself - Rare Message - December	0
Protect Yourself - Frequent Message - December	1

White

Group	Value	95% CI
Passive Control - November	40
Active Control Message - November	57
Ease Message - November	57
Waiting for You Message - November	71
Protect Yourself - Rare Message - November	67
Protect Yourself - Frequent Message - November	50
Passive Control - December	7
Active Control Message - December	24
Ease Message - December	34
Waiting for You Message - December	40
Protect Yourself - Rare Message - December	18
Protect Yourself - Frequent Message - December	25

Two or More

Group	Value	95% CI
Passive Control - November	0
Active Control Message - November	0
Ease Message - November	0
Waiting for You Message - November	0
Protect Yourself - Rare Message - November	0
Protect Yourself - Frequent Message - November	0
Passive Control - December	0
Active Control Message - December	0
Ease Message - December	0
Waiting for You Message - December	0
Protect Yourself - Rare Message - December	0
Protect Yourself - Frequent Message - December	0

Unknown

Group	Value	95% CI
Passive Control - November	0
Active Control Message - November	0
Ease Message - November	0
Waiting for You Message - November	0
Protect Yourself - Rare Message - November	2
Protect Yourself - Frequent Message - November	2
Passive Control - December	1
Active Control Message - December	3
Ease Message - December	1
Waiting for You Message - December	0
Protect Yourself - Rare Message - December	1
Protect Yourself - Frequent Message - December	0

Number of Patients Who Self-Scheduled a Flu Shot by Ethnicity Secondary · Within 4 weeks of the message send date

Hispanic or Latino

Group	Value	95% CI
Passive Control - November	3
Active Control Message - November	2
Ease Message - November	3
Waiting for You Message - November	5
Protect Yourself - Rare Message - November	0
Protect Yourself - Frequent Message - November	1
Passive Control - December	3
Active Control Message - December	1
Ease Message - December	0
Waiting for You Message - December	2
Protect Yourself - Rare Message - December	1
Protect Yourself - Frequent Message - December	2

Not Hispanic or Latino

Group	Value	95% CI
Passive Control - November	40
Active Control Message - November	61
Ease Message - November	59
Waiting for You Message - November	69
Protect Yourself - Rare Message - November	69
Protect Yourself - Frequent Message - November	51
Passive Control - December	5
Active Control Message - December	25
Ease Message - December	36
Waiting for You Message - December	41
Protect Yourself - Rare Message - December	19
Protect Yourself - Frequent Message - December	24

Unable to Obtain

Group	Value	95% CI
Passive Control - November	0
Active Control Message - November	0
Ease Message - November	0
Waiting for You Message - November	0
Protect Yourself - Rare Message - November	1
Protect Yourself - Frequent Message - November	1
Passive Control - December	0
Active Control Message - December	2
Ease Message - December	0
Waiting for You Message - December	1
Protect Yourself - Rare Message - December	0
Protect Yourself - Frequent Message - December	0

Sponsor's own description

The purpose of this study is to test whether messages that make it easy to schedule a flu shot appointment will increase flu shot rates in patients without an upcoming appointment. The study will also test which message versions and message timing are most effective for increasing flu vaccination.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Reminder

Trials testing the same drug.

NCT06566534 — Personalized Nudging to Increase Influenza Vaccinations · NA · completed
NCT06238726 — Nudging Patients to Increase Shingles Vaccination · NA · completed
NCT06123936 — Impact on Influenza Vaccination Rates of a Telephone Text Message Recall From the Attending Physician · NA · unknown
NCT05928689 — Behavioral and Pharmacological Reconsolidation Interference in Misophonia · EARLY_PHASE1 · completed
NCT05341622 — Mailed FIT Outreach 2022 · NA · completed

Other recruiting trials for Influenza

Currently open trials in the same condition.

NCT07215858 — BPL-1357 Against H1N1 Influenza Virus Challenge · Phase 2 · recruiting
NCT07496450 — A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults · Phase 3 · recruiting
NCT07302256 — A Clinical Trial of Influenza Virus Split Vaccine for Individuals Aged 60 Years and Above · Phase 1 · recruiting
NCT07431840 — Immune Defense Protein Impact On Respiratory Immune Outcomes · NA · recruiting
NCT07485855 — Influenza Vaccination Strategy for Patients With Hematologic Malignancy · Phase 3 · recruiting

Other Geisinger Clinic trials

Trials by the same sponsor.

NCT07197801 — Evaluation of a Peer Recovery Support Program Adapted to Target Retention in Clinic-based Medication for Opioid Use Diso · NA · recruiting
NCT06936709 — Perioperative Colchicine for TKA · Phase 4 · not yet recruiting
NCT07042477 — Integrated Telemedicine Program Evaluation · NA · recruiting
NCT07028398 — CMSL Ambulatory Sensitive Condition Nudge Study 2 · NA · recruiting
NCT06696066 — PEERS Pilot: Peer Recovery Support Program to Support Engagement in Medication for Opioid Use Disorder · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05493787 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Geisinger Clinic
Last refreshed: 30 December 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05493787.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing